Photo by lunarts from unsplash
Metformin is an oral anti‐diabetic therapy (ADT) to manage type 2 diabetes mellitus (T2DM), and has been reported to have potential anti‐tuberculosis (TB) effects. This study investigates the risk of… Click to show full abstract
Metformin is an oral anti‐diabetic therapy (ADT) to manage type 2 diabetes mellitus (T2DM), and has been reported to have potential anti‐tuberculosis (TB) effects. This study investigates the risk of active TB among persons with T2DM who were treated with various ADT and insulin therapies.
Keywords:
metformin associated;
associated lower;
risk active;
lower risk;
type diabetes;
tuberculosis
Journal Title: Respirology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Respirology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!